A malignant skin cancer that can also occur in rare sites, driven by melanocytes.
Two unvaccinated residents in Pennsylvania have died from measles, triggering a public health debate. Governor Shapiro says vaccinations could have averted the deaths, while RFK Jr. questions the figures, fueling a political row that experts warn could hinder responses to the outbreak.
Recent reporting shows targeted drugs, immunotherapies and refined radiochemotherapy are prolonging life for cancer patients. Trials indicate higher survival in younger groups and expanding use of genomic profiling. New therapies are pairing with existing treatments to push back relapse and increase quality of life, though access and long-term outcomes vary.
Five or more sunburns raise melanoma risk by up to 80%, with age and burn severity shaping outcomes. Experts urge daily sunscreen and preventive care as cases rise across the United States.
87-year-old sport legend has posted that recent tests are very good and that his immunotherapy is wiping out the cancer. He has battled melanoma, lymphoma, vocal cord cancer and lymph node cancer since 2021, earning the Jimmy V Award for perseverance in 2022.
The experimental mRNA cancer vaccine, intismeran, has been tested in a phase 3 trial with 1,000+ melanoma patients. It is personalised to each patient by analysing tumors and targets neoantigens. When given with pembrolizumab, it aims to boost the immune response and extend cancer-free time. Results indicate reduced recurrence risk, but long-term survival remains to be seen. Trials also explore other cancers.